Duncan Gallagher, Director at Health Catalyst, Inc. (HCAT), sold 4,500 shares at $6.98 ($31K) on 2024-12-23, disclosed to the SEC on 2024-12-27.
Scheduled sale ($31k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |